loader image

Immunology

Immunology

Inflammations has been increasingly identified as a major risk factor across many disease areas particularly in Cardiovascular, immunological and auto-immune diseases. We have extensive experience in Phase 2 to Phase 3 clinical trials including major outcome studies involving anti-inflammatory drugs. Our deep understanding of key inflammatory biomarkers and safety parameters helps in efficient clinical trials designs.

We bring together experts with extensive experience in immunological studies to the table. in conjunction with our other core therapeutic specialty divisions, we can provide you with optimal strategic, scientific, and operational solutions.

Our areas of expertise include:

  • Basic immunology
  • Cancer immunology and immunotherapy
  • Immune Monitoring Core

We have experience working with

Inflammatory bowel disease
Inflammatory bowel disease
Psoriatic arthritis
Psoriatic arthritis
Osteoarthritis
Osteoarthritis
Gout
Gout
Psoriasis
Psoriasis
30000
Patients
1000
Sites
30
TRIALS